Leaderboards/Ocular Diseases and Behçet’s Syndrome

Ocular Diseases and Behçet’s Syndrome

Last updated July 15, 2026

Rising Stars

Fresh ink, massive impact

Researchers

1
Sagang Koo
Seoul National University
2
Vito A. G. Ricigliano
Inserm
3
Nicolas Kitic
Sorbonne Université
4
Zhaoquan Wu
Changsha Medical University
5
Yanguo Su
Ocean University of China
6
Ruyi Qu
Shandong University of Traditional Chinese Medicine
7
Miguel Flores‐Bellver
University of Colorado Anschutz Medical Campus
8
Amol Chhatrapati Bisen
Central Drug Research Institute
9
Binapani Mahaling
Massachusetts Eye and Ear Infirmary
10
Inès Ben Ghezala
Eye Center

Papers

1
Severe Intraocular Inflammation After Intravitreal Injection of Faricimab: A Single-Site Case Series of Six Patients
American Journal of Ophthalmology|2024
37 cit.
2
Publication in ACS Infectious Diseases (2024) [36 citations, W4399430855]
ACS Infectious Diseases|2024
36 cit.
3
Publication in Journal of Nanotheranostics (2024) [12 citations, W4403187621]
Journal of Nanotheranostics|2024
12 cit.
4
Publication in Inflammation (2024) [11 citations, W4397039502]
Inflammation|2024
11 cit.
5
Publication in Journal of Materials Chemistry B (2024) [11 citations, W4398150263]
Journal of Materials Chemistry B|2024
11 cit.
6
Publication in Chemistry & Biodiversity (2024) [10 citations, W4391436300]
Chemistry & Biodiversity|2024
10 cit.
7
Publication in Bioanalysis (2024) [9 citations, W4390702606]
Bioanalysis|2024
9 cit.
8
Publication in Journal of Mass Spectrometry (2024) [6 citations, W4396804229]
Journal of Mass Spectrometry|2024
6 cit.
9
Generation of Induced-Primary Retinal Pigment Epithelium from Human Retinal Organoids
Methods in molecular biology|2024
4 cit.
10
How Can Pharmacology Help Us Overcome the Challenges of Drug Repositioning as Antivirals to Treat Emerging Pathogens? The Example of Covid‐19
Clinical and Translational Science|2026
4 cit.

Emerging Leaders

Drafting the new consensus

Researchers

1
Olga Ziouzina
University of Calgary
2
Rachael L. Niederer
University of Auckland
3
Ali Akman
Istanbul Commerce University
4
Ching‐Yi Cheng
Chang Gung University of Science and Technology
5
Yi-Hong Wu
Dongguan People’s Hospital
6
Parthopratim Dutta Majumder
Sankara Nethralaya
7
Alessandro Invernizzi
University of Milan
8
Matthew Pilgrim
University College London
9
Edoardo Trovato Battagliola
Policlinico Umberto I
10
Bing‐Dong Sui
Air Force Medical University

Papers

1
Ten-Year Incidence of Fibrosis and Risk Factors for Its Development in Neovascular Age-Related Macular Degeneration
American Journal of Ophthalmology|2023
49 cit.
2
Anti-Inflammatory Effect of Resveratrol Derivatives via the Downregulation of Oxidative-Stress-Dependent and c-Src Transactivation EGFR Pathways on Rat Mesangial Cells
Antioxidants|2022
31 cit.
3
Targeted inhibition of osteoclastogenesis reveals the pathogenesis and therapeutics of bone loss under sympathetic neurostress
International Journal of Oral Science|2022
24 cit.
4
Objective Quantification of Posterior Segment Inflammation: Measuring Vitreous Cells and Haze Using Optical Coherence Tomography
American Journal of Ophthalmology|2022
24 cit.
5
Uveitis in Sarcoidosis – Clinical Features and Comparison with Other Non-infectious Uveitis
Ocular Immunology and Inflammation|2022
19 cit.
6
Neurotrophic Keratopathy After Herpes Zoster Ophthalmicus
Cornea|2022
18 cit.
7
CORM-2 prevents human gingival fibroblasts from lipoteichoic acid-induced VCAM-1 and ICAM-1 expression by inhibiting TLR2/MyD88/TRAF6/PI3K/Akt/ROS/NF-κB signaling pathway
Biochemical Pharmacology|2022
18 cit.
8
Region-specific sympatho-adrenergic regulation of specialized vasculature in bone homeostasis and regeneration
iScience|2023
18 cit.
9
Long term complications and vision loss in HLA-B27 uveitis
Eye|2022
17 cit.
10
Navigating Coronavirus Disease 2019 Vaccination and Uveitis
Ophthalmology|2022
16 cit.

Current Senior Leaders

Wrote the book, still writing it

Researchers

1
C. Stephen Foster
Massachusetts Eye and Ear Infirmary
2
Aize Kijlstra
Maastricht University
3
Hasan Yazıcı
Istanbul University
4
Rachel R Caspi
National Institutes of Health
5
Peizeng Yang
Henan Provincial Eye Hospital
6
Susan Lightman
University College London
7
Carl P. Herbort
Centre for Sight
8
Manabu Mochizuki
Veterinary Medical Center
9
Narsing A. Rao
Southern California Eye Institute
10
Aniki Rothová
Erasmus MC

Papers

1
Causes and frequency of blindness in patients with intraocular inflammatory disease.
British Journal of Ophthalmology|1996
902 cit.
2
2018 update of the EULAR recommendations for the management of Behçet's syndrome
Annals of the Rheumatic Diseases|2018
773 cit.
3
The Long-Term Mortality and Morbidity of Behçet Syndrome
Medicine|2003
757 cit.
4
EULAR recommendations for the management of Behçet disease
Annals of the Rheumatic Diseases|2008
721 cit.
5
Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category
The Journal of Experimental Medicine|2008
714 cit.
6
The<i>Rd8</i>Mutation of the<i>Crb1</i>Gene Is Present in Vendor Lines of C57BL/6N Mice and Embryonic Stem Cells, and Confounds Ocular Induced Mutant Phenotypes
Investigative Ophthalmology & Visual Science|2012
698 cit.
7
A Controlled Trial of Azathioprine in Behçet's Syndrome
New England Journal of Medicine|1990
647 cit.
8
MetaCyc: a multiorganism database of metabolic pathways and enzymes
Nucleic Acids Research|2005
626 cit.
9
Incidence of contact-lens-associated microbial keratitis and its related morbidity
The Lancet|1999
608 cit.
10
The MetaCyc database of metabolic pathways and enzymes and the BioCyc collection of pathway/genome databases
Nucleic Acids Research|2011
608 cit.

Reagents for Ocular Diseases and Behçet’s Syndrome

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

Cell Signaling Technology

Cleaved Drosophila ICE (drICE) (Asp230) Antibody

#9478$362
View Evidence →
ProteintechEvidence 69

TMEM173/STING Polyclonal antibody

#19851-1-AP
View Evidence →
Cell Signaling TechnologyEvidence 66

Acetyl-Histone H3 (Lys9) (C5B11) Rabbit Monoclonal Antibody (HRP Conjugate)

#14052$493
View Evidence →

🌟 All-Time

Most validated

Cell Signaling TechnologyEvidence 60

PathScan® Phospho-Met (Tyr1234/1235) Sandwich ELISA Kit

#7227$66,129,740
View Evidence →
Cell Signaling Technology

PathScan® Acetylated Histone H3 Sandwich ELISA Kit

#7232$66,129,740
View Evidence →
Cell Signaling TechnologyEvidence 67

Vimentin (D21H3) Rabbit Monoclonal Antibody (Alexa Fluor® 555 Conjugate)

#9855$180,465
View Evidence →